Pancreatic Cancer Research

ResearcherXiangya Hospital Central South UniversityActive in the last 2 years

Hui Gong

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-2389-7688; OpenAlex author ID A5101888612.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Association between diabetes duration and risk of pancreatic cancer: a meta-analysis of observational studies. Last author DOI 10.1097/meg.0000000000003041↗
  2. Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis. Co-author DOI 10.18632/oncotarget.17728↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Xuefeng Hua · 1 shared paper, 2026
  2. Dong-Chu Zhou · 1 shared paper, 2017
  3. Jian-Quan Luo · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.